What is PLRZ's current stock price?

PLRZ (Polyrizon Ltd.) is currently trading at $15.26 with a market cap of $17.1M.

What sector is Polyrizon Ltd. in?

Polyrizon Ltd. (PLRZ) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

PLRZ Polyrizon Ltd.

Healthcare

$15.26+20.59%ClosedMarket Cap: $17.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.17

P/S

0.00

EV/EBITDA

-3.55

DCF Value

$0.81

FCF Yield

-20.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-26.1%

ROA

-19.2%

ROIC

-17.9%

Financials

View All

Period	Revenue	Net Income	EPS
Q4 null	$0.00	$-3.2M	$—
FY null	$0.00	$-3.3M	$—
Q2 null	$0.00	$-88.50	$—
Q1 null	$0.00	$-88.50	$—

Trading Activity

Insider Trades

View All

Izraeli Tomerdirector, officer: Chief Executive Officer

SellWed Apr 01

Carmel Lirondirector

SellWed Apr 01

Adler Ozdirector

SellWed Apr 01

Turgeman Tidhardirector, officer: Chief Technology Officer

SellTue Mar 31

Izraeli Tomerdirector, officer: Chief Executive Officer

SellTue Mar 31

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-1.98

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Peers

AIM

NBY